Additionally, STAT3 inhibition attenuates resistance to anticancer chemo- and radiotherapy.7 Furthermore, STAT3 inhibition prevents the transition of normal cells into tumor cells making this oncogenic protein an attractive target for cancer drug discovery.8–10. This evidence concerns the gene STAT3 and cancer.